SNIPR BIOME, Denmark, announced today that it has dosed the first human subjects in its Phase 1 clinical trial for SNIPR001, an orally administered...

In our first clinical update of 2022, we look at three new IND approvals for gene-edited therapies for life-threatening E. coli infections,...

In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...

Researchers use the M13 bacteriophage to deliver a CRISPR-Cas9 system to Escherichia coli in the mouse gut. The approach marks the first-ever use of...

Two weeks ago, we hosted a CMN webinar on CRISPR Delivery Systems. Several hundred attendees from all continents tuned in for the live event. Here's a...